Praetego

Durham, United States

Praetego is a pharmaceutical company focused on addressing serious diabetic complications.

$300K raised

Mar 2023

Grant

Health Care Health Diagnostics Medical Pharmaceutical

Top Investors

Stony Lonesome Group National Institute on Aging National Eye Institute National Institute of Diabetes and Digestive and Kidney Diseases

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Praetego

How much funding has Praetego raised?

Praetego has raised $300K in total funding. The most recent round was Grant. The last funding was announced in March 2023.

Who are Praetego's investors?

Praetego's investors include Stony Lonesome Group, National Institute on Aging, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Where is Praetego headquartered?

Praetego is headquartered in Durham, United States.

What does Praetego do?

Praetego is a pharmaceutical company focused on addressing serious diabetic complications.

What stage is Praetego at?

Praetego is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2023.

MLA

"Praetego — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/praetego. Accessed July 2, 2026.

APA

VCBacked. (2023). Praetego — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/praetego

Wikipedia (cite web)

{{cite web |title=Praetego — Funding & Investors |url=https://www.vcbacked.co/company/praetego |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2023.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics